Paclitaxel-Based Chemoradiotherapy in Localized Gastric Carcinoma: Degree of Pathologic Response and Not Clinical Parameters Dictated Patient Outcome

Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction

2001 • 3,402 citations

Extended Lymph-Node Dissection for Gastric Cancer

1999 • 1,567 citations

Cancer of the Stomach

1993 • 674 citations

The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis.

2000 • 601 citations

The National Cancer Data Base report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy

2000 • 437 citations

Multi-Institutional Trial of Preoperative Chemoradiotherapy in Patients With Potentially Resectable Gastric Carcinoma

2004 • 331 citations

Activity of Taxol in Patients With Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus

1994 • 264 citations

Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.

1998 • 202 citations

Laparoscopic staging for gastric cancer

1996 • 179 citations

Phase II study of Taxol in patients with advanced gastric carcinoma.

1998 • 136 citations

Perioperative chemotherapy in operable gastric and lower oesophageal cancer: Final results of a randomised, controlled trial (the MAGIC trial, ISRCTN 93793971)

2005 • 120 citations

Laparoscopy in 533 patients with abdominal malignancy

1999 • 63 citations

Paclitaxel and concurrent radiation for gastric cancer

2000 • 33 citations

Perioperative chemotherapy in operable gastric and lower oesophageal cancer: final results of a randomised, controlled trial (the MAGIC trial, ISRCTN 93793971)

2005 • 17 citations